A Study of Tralokinumab When Delivered Subcutaneously at Different Flow Rates to Healthy Volunteers

Clinical trial NCT02085473 · COMPLETED

Trial details

NCT number: NCT02085473
Sponsor: MedImmune LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Asthma Healthy Subjects or Volunteers

Start date: 2014-03-19
Primary completion: 2014-07-10
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.